| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | M9BYU8XDQ6 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | DNA topoisomerase I inhibitor | FDA |
| Primary Target | |
|---|---|
| tumor associated calcium signal transducer 2 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 4 | D001943 | ClinicalTrials |
| Triple Negative Breast Neoplasms | 4 | D064726 | FDA |
| Breast Neoplasms | 4 | D001943 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1491917-83-9 |
| ChEMBL | CHEMBL3545262 |
| FDA SRS | M9BYU8XDQ6 |
| Guide to Pharmacology | 8253 |
| PubChem | 91668186 |
CONTENTS